Elizabeth Rozek insider trades: Sagimet Biosciences (SGMT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Elizabeth reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | SGMT | ↓ Sell | 10,545 | $7.76 | $82K | Direct | Jul 22, 2026 (2d) |
| Feb 10, 2026 | SGMT | ↓ Sell | 2,622 | $5.36 | $14K | Direct | Feb 12, 2026 (2d) |
| Jul 21, 2025 | SGMT | ↓ Sell | 10,780 | $9.13 | $98K | Direct | Jul 23, 2025 (2d) |
| Jul 19, 2024 | SGMT | ↓ Sell | 10,914 | $3.10 | $34K | Direct | Jul 23, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGMT insiders
Open-market trades in the last 12 months
About Elizabeth Rozek's insider trades
Elizabeth Rozek is Chief Legal & Admin. Officer at Sagimet Biosciences (SGMT). Since Jul 19, 2024, Elizabeth has reported no open-market purchases and 4 sales worth $228K on SEC Form 4. In the last 12 months: 2 sales ($96K).
Their filings also include grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGMT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.